1. Home
  2. GHG vs LUNG Comparison

GHG vs LUNG Comparison

Compare GHG & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.15

Market Cap

119.1M

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.43

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
LUNG
Founded
2004
1995
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.1M
57.9M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
GHG
LUNG
Price
$1.15
$1.43
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$5.38
AVG Volume (30 Days)
7.7K
568.9K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
4.15%
N/A
EPS Growth
N/A
7.64
EPS
N/A
N/A
Revenue
N/A
$90,497,000.00
Revenue This Year
$19.02
$2.48
Revenue Next Year
$8.26
$18.46
P/E Ratio
$5.76
N/A
Revenue Growth
N/A
8.01
52 Week Low
$1.11
$1.13
52 Week High
$2.78
$3.88

Technical Indicators

Market Signals
Indicator
GHG
LUNG
Relative Strength Index (RSI) 48.76 50.96
Support Level $1.14 $1.22
Resistance Level $1.16 $1.45
Average True Range (ATR) 0.02 0.12
MACD 0.00 0.01
Stochastic Oscillator 80.00 53.12

Price Performance

Historical Comparison
GHG
LUNG

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: